Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Beth Seidenberg
Age : 63
Public asset : 3,445,613 USD
Country of residence : Unknown
Linked companies : Progyny, Inc. - Atara Biotherapeutics, Inc. - Vera Therapeutics, Inc.

Biography of Beth Seidenberg 
Dr. Beth C. Seidenberg, MD, is a Managing Director at Westlake Biopartners LLC, an Independent Director at Vera Therapeutics, Inc., an Independent Director at Atara Biotherapeutics, Inc., a Chairman at Progyny, Inc., a Chairman at Sagimet Biosciences, Inc. and a Partner & Advisor at Kleiner Perkins Caufield & Byers LLC. She is on the Board of Directors at Expansion Therapeutics, Inc., Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., ACELYRIN, Inc., Arsenal Biosciences, Inc., Auxogyn, Inc., Breathe Technologies, Inc., Cell Design Labs, Inc., Kyverna Therapeutics, Inc., Mango Health, Inc., Spruce Health, Inc., Tmunity Therapeutics, Inc. and True North Therapeutics, Inc. Dr. Seidenberg was previously employed as an Independent Director by Epizyme, Inc., a Chief Medical Officer & SVP-Global Development by Amgen, Inc., a Senior Vice President-Global Development by Bristol Myers Squibb Co., a VP-Immunology, Pulmonary & Dermatology by Merck Research Laboratories Massachusetts LLC, a Chairman by Arresto BioSciences, Inc., a Chairman by Flexus Biosciences, Inc., a Senior Executive-Research & Development by Merck & Co., Inc., and a Researcher by National Institutes of Health. She also served on the board at Practice Fusion, Inc., ARMO BioSciences, Inc., Tesaro, Inc., BioCryst Pharmaceuticals, Inc., iPierian, Inc., Livongo Health, Inc., Rapt Therapeutics, Inc. and RedBrick Health Corp. She received her undergraduate degree from Barnard College and a doctorate degree from The University of Miami Leonard M. Miller School of Medicine.


Current positions of Beth Seidenberg 
Holdings of Beth Seidenberg 
Beth Seidenberg : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09:11aSTELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Beth Seidenberg : Connections 


Latest news about Beth Seidenberg 
2020Kyverna Therapeutics, Inc. announced that it has received $25 million in funding from Vida Ventures, Westlake Village BioPartners, Gilead Sciences, Inc.
CI
2019Trucode Launched to Advance Next-Generation Gene Editing Platform; Announces Board Appointments
CI
2019Epizyme, Inc. Announces Board Changes
CI
2019GlaxoSmithKline plc completed the acquisition of Tesaro, Inc. from Leon O. Moulder, Mary Lynne Hedley, New Enterprise Associates, Kleiner Perkins, Sofinnova Investment, Inc. and others.
CI
2014Biopharma veteran Gallagher to join venture capital firm NEA
RE
2014Despite lip service, Silicon Valley venture capital still a man’s world
RE
2013INSIGHT : How cleantech tarnished Kleiner and VC star John Doerr
RE
More news